Terms: = Ovarian cancer AND PAX3, MGC120382, 5077, ENSG00000135903, CDHS, MGC120383, HUP2, P23760, WS1, MGC120384, MGC134778, MGC120381
3 results:
1. Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (pax3) in epithelial ovarian cancer.
Han GH; Chay DB; Nam S; Cho H; Chung JY; Kim JH
BMC Cancer; 2019 Dec; 19(1):1202. PubMed ID: 31823759
[TBL] [Abstract] [Full Text] [Related]
2. Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin.
Decio A; Cesca M; Bizzaro F; Porcu L; Bettolini R; Ubezio P; Taraboletti G; Belotti D; Giavazzi R
Clin Exp Metastasis; 2015 Oct; 32(7):647-58. PubMed ID: 26185056
[TBL] [Abstract] [Full Text] [Related]
3. Rapidly progressive congenital rhabdomyosarcoma presenting with multiple cutaneous lesions: an uncommon diagnosis and a therapeutic challenge.
Rekhi B; Qureshi SS; Narula G; Gujral S; Kurkure P
Pathol Res Pract; 2014 May; 210(5):328-33. PubMed ID: 24635971
[TBL] [Abstract] [Full Text] [Related]
